Skip to main content
. 2016 Nov 2;7(50):82620–82633. doi: 10.18632/oncotarget.13012

Figure 7. PVT1 promotes tumor growth in vivo.

Figure 7

(A) Statistical analysis of changes in tumor volume in vivo. (B) Representative image of tumor formation in nude mice 35 days after the subcutaneous administration of Lv-shRNA-PVT1#1 and Lv-control cells. (CG) The results of qRT-PCR analyses for PVT1, miR-195, BCL2, CCND1 and FASN after PVT1 silencing in vivo (**P < 0.05).